Best Biotech Stocks to Buy Now (2023)Top biotech stocks in 2023 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Consensus | Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $705.13M | $26.51 | $53.00 | 99.92% | Strong Buy | 4 | 48.55% | 79.94% | N/A | N/A | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.24B | $37.35 | $59.43 | 59.11% | Strong Buy | 7 | 23.27% | 14.55% | N/A | N/A | |
| VYGR | VOYAGER THERAPEUTICS INC | $337.81M | $7.70 | $16.00 | 107.93% | Strong Buy | 3 | -70.03% | N/A | N/A | N/A | |
| OCUP | OCUPHIRE PHARMA INC | $83.19M | $3.96 | $18.50 | 367.17% | Strong Buy | 2 | 15.96% | -48.65% | N/A | N/A | |
| UTHR | UNITED THERAPEUTICS CORP | $10.51B | $223.93 | $297.17 | 32.71% | Strong Buy | 6 | 8.30% | 6.42% | N/A | N/A | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $1.19B | $16.93 | $32.00 | 89.01% | Strong Buy | 1 | 23.76% | N/A | N/A | N/A | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $16.63B | $88.38 | $113.41 | 28.32% | Buy | 17 | 21.17% | 99.74% | N/A | N/A | |
| TECH | BIO-TECHNE CORP | $11.21B | $70.87 | $101.50 | 43.22% | Strong Buy | 4 | 21.86% | 22.81% | 21.96% | 16.36% | |
| GMAB | GENMAB A | $24.72B | $37.43 | $45.50 | 21.56% | Buy | 4 | 14.45% | 29.05% | N/A | N/A | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | $452.09M | $10.82 | $23.00 | 112.57% | Buy | 8 | 35.12% | 6.32% | N/A | N/A | |
| CPRX | CATALYST PHARMACEUTICALS INC | $1.30B | $12.18 | $25.00 | 105.25% | Strong Buy | 3 | -3.72% | -3.96% | N/A | N/A | |
| PGEN | PRECIGEN INC | $357.68M | $1.40 | $10.00 | 614.29% | Buy | 2 | 32.54% | N/A | N/A | N/A | |
| LGND | LIGAND PHARMACEUTICALS INC | $1.06B | $61.06 | $116.33 | 90.52% | Strong Buy | 3 | 24.35% | 8.92% | N/A | N/A | |
| INCY | INCYTE CORP | $13.53B | $60.37 | $82.55 | 36.73% | Buy | 11 | 13.61% | 68.58% | N/A | N/A | |
| TBPH | THERAVANCE BIOPHARMA INC | $478.49M | $9.06 | $20.00 | 120.75% | Buy | 1 | 28.42% | N/A | N/A | N/A | |
| HALO | HALOZYME THERAPEUTICS INC | $5.22B | $39.60 | $56.00 | 41.41% | Strong Buy | 6 | 16.01% | 46.34% | N/A | N/A | |
| CMRX | CHIMERIX INC | $93.46M | $1.06 | $8.00 | 658.29% | Buy | 3 | -18.73% | N/A | N/A | N/A | |
| LIFE | ATYR PHARMA INC | $92.41M | $1.62 | $24.67 | 1,422.65% | Strong Buy | 3 | 58.60% | N/A | N/A | N/A | |
| EXEL | EXELIXIS INC | $6.85B | $21.51 | $25.63 | 19.13% | Strong Buy | 8 | 13.35% | 58.22% | N/A | N/A | |
| VNDA | VANDA PHARMACEUTICALS INC | $246.14M | $4.28 | N/A | N/A | N/A | N/A | 5.16% | 5.46% | N/A | N/A | |
| MRNA | MODERNA INC | $39.40B | $103.53 | $142.33 | 37.48% | Buy | 9 | -0.04% | 20.78% | N/A | N/A | |
| ZYME | ZYMEWORKS INC | $450.37M | $6.64 | $13.20 | 98.80% | Buy | 5 | -34.31% | N/A | N/A | N/A | |
| LPCN | LIPOCINE INC | $17.12M | $3.22 | $33.00 | 924.84% | Strong Buy | 1 | 1,792.74% | N/A | 28.49% | 26.68% | |
| APRE | APREA THERAPEUTICS INC | $16.25M | $4.35 | $20.00 | 359.77% | Buy | 1 | 786.80% | N/A | N/A | N/A | |
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $69.57M | $6.10 | $11.00 | 80.33% | Buy | 1 | 142.67% | N/A | N/A | N/A | |
| PRTA | PROTHENA CORP PUBLIC LTD CO | $2.81B | $52.50 | $88.40 | 68.38% | Buy | 5 | 58.57% | N/A | N/A | N/A | |
| CLNN | CLENE INC | $61.89M | $0.48 | $7.20 | 1,393.78% | Strong Buy | 5 | 810.63% | N/A | N/A | N/A | |
| GTHX | G1 THERAPEUTICS INC | $69.34M | $1.34 | $11.40 | 750.75% | Buy | 5 | 36.53% | N/A | N/A | N/A | |
| ENTX | ENTERA BIO LTD | $19.74M | $0.69 | $10.00 | 1,359.85% | Buy | 1 | 601.97% | N/A | N/A | N/A | |
| GNFT | GENFIT SA | $185.39M | $3.72 | $11.00 | 195.70% | Buy | 1 | 37.80% | N/A | N/A | N/A | |
| AGIO | AGIOS PHARMACEUTICALS INC | $1.37B | $24.56 | $37.00 | 50.65% | Buy | 2 | 119.91% | N/A | N/A | N/A | |
| NRBO | NEUROBO PHARMACEUTICALS INC | $20.33M | $0.53 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| VRCA | VERRICA PHARMACEUTICALS INC | $168.26M | $4.00 | $11.50 | 187.50% | Strong Buy | 4 | 136.89% | N/A | N/A | N/A | |
| CRSP | CRISPR THERAPEUTICS AG | $3.70B | $46.56 | $71.00 | 52.49% | Buy | 14 | 109.39% | N/A | N/A | N/A | |
| SELB | SELECTA BIOSCIENCES INC | $164.17M | $1.07 | $3.25 | 203.74% | Buy | 4 | 20.14% | N/A | N/A | N/A | |
| CRDF | CARDIFF ONCOLOGY INC | $72.82M | $1.63 | $12.00 | 636.20% | Buy | 1 | 269.34% | N/A | N/A | N/A | |
| STOK | STOKE THERAPEUTICS INC | $196.50M | $4.44 | $22.17 | 399.26% | Buy | 6 | 76.80% | N/A | N/A | N/A | |
| BCYC | BICYCLE THERAPEUTICS PLC | $894.27M | $21.59 | $49.00 | 126.96% | Strong Buy | 8 | 40.29% | N/A | N/A | N/A | |
| AUPH | AURINIA PHARMACEUTICALS INC | $1.20B | $8.34 | $15.00 | 79.86% | Strong Buy | 2 | 47.67% | N/A | N/A | N/A | |
| AUTL | AUTOLUS THERAPEUTICS PLC | $481.10M | $2.77 | $7.50 | 170.76% | Strong Buy | 4 | 174.11% | N/A | N/A | N/A | |
| CARM | CARISMA THERAPEUTICS INC | $178.06M | $4.42 | $11.00 | 148.87% | Buy | 3 | 36.40% | N/A | N/A | N/A | |
| VBLT | VASCULAR BIOGENICS LTD | $17.16M | $0.22 | N/A | N/A | N/A | N/A | 8.19% | N/A | N/A | N/A | |
| ORTX | ORCHARD THERAPEUTICS PLC | $160.42M | $7.06 | $24.50 | 247.03% | Strong Buy | 2 | 54.73% | N/A | -562.62% | -264.11% | |
| ZLAB | ZAI LAB LTD | $2.50B | $25.39 | $87.50 | 244.62% | Strong Buy | 3 | 81.16% | N/A | N/A | N/A | |
| ALLO | ALLOGENE THERAPEUTICS INC | $631.95M | $3.77 | $18.06 | 378.94% | Buy | 9 | 818.01% | N/A | N/A | N/A | |
| XENE | XENON PHARMACEUTICALS INC | $2.30B | $35.84 | $51.67 | 44.16% | Strong Buy | 6 | 748.34% | N/A | N/A | N/A | |
| SPRO | SPERO THERAPEUTICS INC | $64.82M | $1.23 | $7.00 | 469.11% | Buy | 1 | N/A | N/A | N/A | N/A | |
| AXSM | AXSOME THERAPEUTICS INC | $3.48B | $73.70 | $108.43 | 47.12% | Strong Buy | 7 | 50.90% | N/A | N/A | N/A | |
| EDIT | EDITAS MEDICINE INC | $648.98M | $7.95 | $14.00 | 76.10% | Buy | 6 | 83.65% | N/A | N/A | N/A | |
| SLGL | SOL-GEL TECHNOLOGIES LTD | $58.67M | $2.11 | $9.50 | 350.24% | Strong Buy | 2 | 120.97% | N/A | N/A | N/A | |
| DNLI | DENALI THERAPEUTICS INC | $3.05B | $22.22 | $65.00 | 192.53% | Strong Buy | 6 | -3.45% | N/A | N/A | N/A | |
| ONTX | ONCONOVA THERAPEUTICS INC | $15.98M | $0.76 | $11.00 | 1,343.57% | Buy | 1 | 32.74% | N/A | -120.99% | -75.05% | |
| VRNA | VERONA PHARMA PLC | $1.35B | $16.94 | $32.25 | 90.38% | Strong Buy | 4 | 646.96% | N/A | N/A | N/A | |
| CARA | CARA THERAPEUTICS INC | $96.80M | $1.79 | $16.50 | 821.79% | Buy | 6 | 121.89% | N/A | N/A | N/A | |
| LUMO | LUMOS PHARMA INC | $23.01M | $2.90 | $18.33 | 532.17% | Strong Buy | 3 | 143.98% | N/A | N/A | N/A | |
| DOMH | DOMINARI HOLDINGS INC | $13.68M | $2.56 | N/A | N/A | N/A | N/A | 28,069.01% | N/A | -19.12% | -17.45% | |
| BNTX | BIONTECH SE | $26.04B | $108.61 | $150.73 | 38.78% | Buy | 11 | -32.29% | -60.03% | N/A | N/A | |
| MDWD | MEDIWOUND LTD | $65.63M | $9.05 | $29.50 | 225.97% | Buy | 2 | 32.16% | N/A | N/A | N/A | |
| CGEN | COMPUGEN LTD | $90.00M | $1.02 | $8.00 | 684.31% | Strong Buy | 3 | 104.25% | N/A | N/A | N/A | |
| VRDN | VIRIDIAN THERAPEUTICS INC | $714.88M | $16.37 | $42.56 | 159.96% | Strong Buy | 9 | 358.06% | N/A | N/A | N/A | |
| PLUR | PLURI INC | $24.81M | $0.60 | N/A | N/A | N/A | N/A | 251.99% | N/A | 1,531.15% | 402.55% | |
| PLX | PROTALIX BIOTHERAPEUTICS INC | $122.40M | $1.71 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| CORT | CORCEPT THERAPEUTICS INC | $3.29B | $32.04 | $30.40 | -5.12% | Buy | 5 | 10.80% | 26.58% | N/A | N/A | |
| MGNX | MACROGENICS INC | $281.25M | $4.54 | $12.00 | 164.32% | Strong Buy | 3 | 29.44% | N/A | N/A | N/A | |
| DTIL | PRECISION BIOSCIENCES INC | $49.48M | $0.43 | $2.50 | 481.40% | Strong Buy | 2 | 65.68% | N/A | N/A | N/A | |
| MRKR | MARKER THERAPEUTICS INC | $47.13M | $5.35 | N/A | N/A | N/A | N/A | 73.14% | N/A | N/A | N/A | |
| QURE | UNIQURE NV | $356.35M | $7.47 | $41.00 | 448.86% | Strong Buy | 6 | 22.12% | N/A | N/A | N/A | |
| RNA | AVIDITY BIOSCIENCES INC | $523.12M | $7.06 | $31.60 | 347.59% | Strong Buy | 5 | 184.46% | N/A | N/A | N/A | |
| FULC | FULCRUM THERAPEUTICS INC | $273.87M | $4.43 | $11.00 | 148.31% | Buy | 4 | 94.44% | N/A | N/A | N/A | |
| MRSN | MERSANA THERAPEUTICS INC | $153.04M | $1.27 | $4.60 | 262.20% | Hold | 5 | 56.92% | N/A | N/A | N/A | |
| SAGE | SAGE THERAPEUTICS INC | $1.19B | $19.90 | $29.87 | 50.09% | Hold | 15 | 259.74% | N/A | N/A | N/A | |
| REGN | REGENERON PHARMACEUTICALS INC | $90.28B | $831.62 | $907.89 | 9.17% | Strong Buy | 18 | 1.80% | 1.39% | N/A | N/A | |
| BLUE | BLUEBIRD BIO INC | $336.90M | $3.15 | $6.70 | 112.76% | Buy | 6 | 165.53% | N/A | N/A | N/A | |
| PULM | PULMATRIX INC | $7.93M | $2.17 | $10.00 | 360.83% | Buy | 1 | 24.89% | N/A | N/A | N/A | |
| MESO | MESOBLAST LTD | $213.32M | $1.31 | $6.83 | 421.60% | Hold | 3 | 436.04% | N/A | 1,110.56% | 832.55% | |
| DBVT | DBV TECHNOLOGIES SA | $282.02M | $1.47 | $7.00 | 377.82% | Buy | 2 | 201.62% | N/A | N/A | N/A | |
| SEER | SEER INC | $150.26M | $2.35 | N/A | N/A | N/A | N/A | 90.24% | N/A | N/A | N/A | |
| JANX | JANUX THERAPEUTICS INC | $451.24M | $9.78 | $29.50 | 201.64% | Buy | 2 | 342.04% | N/A | -48.38% | -42.42% | |
| NRIX | NURIX THERAPEUTICS INC | $444.89M | $9.23 | $26.60 | 188.19% | Buy | 5 | 36.14% | N/A | N/A | N/A | |
| IMGN | IMMUNOGEN INC | $3.64B | $14.64 | $23.00 | 57.16% | Strong Buy | 7 | 38.87% | N/A | N/A | N/A | |
| AMLX | AMYLYX PHARMACEUTICALS INC | $1.25B | $18.57 | $49.67 | 167.53% | Strong Buy | 3 | 60.34% | N/A | N/A | N/A | |
| CALT | CALLIDITAS THERAPEUTICS AB | $487.96M | $16.38 | $34.00 | 107.57% | Buy | 2 | 81.44% | N/A | N/A | N/A | |
| TFFP | TFF PHARMACEUTICALS INC | $12.18M | $0.34 | $5.50 | 1,536.90% | Strong Buy | 2 | 471.77% | N/A | N/A | N/A | |
| LQDA | LIQUIDIA CORP | $406.57M | $6.28 | $12.33 | 96.39% | Hold | 3 | 97.99% | N/A | N/A | N/A | |
| IMNN | IMUNON INC | $10.21M | $1.09 | $12.00 | 1,000.92% | Buy | 1 | 283.06% | N/A | N/A | N/A | |
| IGMS | IGM BIOSCIENCES INC | $406.81M | $6.97 | $20.67 | 196.51% | Buy | 6 | 292.50% | N/A | N/A | N/A | |
| ACST | ACASTI PHARMA INC | $14.30M | $1.92 | N/A | N/A | N/A | N/A | N/A | N/A | 13.26% | 11.63% | |
| SGMO | SANGAMO THERAPEUTICS INC | $149.13M | $0.84 | $6.07 | 621.02% | Buy | 7 | 11.29% | N/A | N/A | N/A | |
| ENTA | ENANTA PHARMACEUTICALS INC | $265.72M | $12.62 | $31.60 | 150.40% | Hold | 5 | 93.62% | N/A | N/A | N/A | |
| CLLS | CELLECTIS SA | $90.60M | $1.63 | $11.00 | 574.85% | Strong Buy | 3 | 108.25% | N/A | N/A | N/A | |
| INO | INOVIO PHARMACEUTICALS INC | $104.55M | $0.39 | $2.00 | 412.82% | Hold | 1 | 86.57% | N/A | N/A | N/A | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $1.57B | $28.62 | $45.14 | 57.73% | Strong Buy | 7 | 116.77% | N/A | N/A | N/A | |
| AADI | AADI BIOSCIENCE INC | $128.48M | $5.24 | $45.00 | 758.78% | Buy | 1 | 12.83% | N/A | N/A | N/A | |
| NTLA | INTELLIA THERAPEUTICS INC | $3.01B | $33.99 | $75.77 | 122.92% | Strong Buy | 13 | 44.00% | N/A | N/A | N/A | |
| MIRM | MIRUM PHARMACEUTICALS INC | $1.19B | $31.08 | $72.33 | 132.73% | Strong Buy | 3 | 58.24% | N/A | N/A | N/A | |
| MIST | MILESTONE PHARMACEUTICALS INC | $97.81M | $2.93 | $14.00 | 377.82% | Buy | 3 | 201.85% | N/A | N/A | N/A | |
| ARVN | ARVINAS INC | $1.30B | $24.23 | $62.30 | 157.12% | Strong Buy | 10 | 25.17% | N/A | N/A | N/A | |
| LXRX | LEXICON PHARMACEUTICALS INC | $284.11M | $1.16 | $8.00 | 589.66% | Strong Buy | 1 | 701.33% | N/A | N/A | N/A | |
| VIR | VIR BIOTECHNOLOGY INC | $1.26B | $9.37 | $35.83 | 282.42% | Buy | 6 | 4.38% | N/A | N/A | N/A | |
| CUE | CUE BIOPHARMA INC | $104.76M | $2.33 | $11.00 | 372.10% | Strong Buy | 3 | 136.40% | N/A | N/A | N/A |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.